RxDoctor Payments Data

Jessica Schardein, MD

Urology · Louisville, KYNPI 1467984955

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (53.6%), food and beverage and education — rather than concentrated in one kind of arrangement. Coloplast accounts for 67.2% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $3,717 and has fallen 71.3% since, to $1,067 in 2025.

$9,299in general payments, 2019–2025

Across 93 payments — averaging $99.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coloplast$6K
  • Boston Scientific$3K
  • Endo USA, Inc.$96
  • Antares Pharma, Inc.$50
  • Tolmar, Inc.$35
  • Sumitomo Pharma America, Inc.$34
  • plus $111 from 4 others

What the payments were for

  • Travel & lodging$4,98454%
  • Food & beverage$4,14545%
  • Education$1702%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,299 in reported general payments places this provider in the 85th percentile of 139 urology providers in Kentucky.

See all urology providers in Kentucky

Medicare billing

Part B allowed, 2024
$12,563
Medicare patients
48
Services billed
88

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl13$192
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim22$103
Oxycodone Hcl21$26

Paid to pharmacies, not to this prescriber.

Other urology in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →